Overall (n=278) | cTnT negative (n=230) | cTnT positive (n=48) | |
---|---|---|---|
Data are n (%). *p<0.01; **p<0.001 versus cTnT negative. | |||
AHA/ACC, American Heart Association/American College of Cardiology; LAD, left anterior descending artery; LCX, left circumflex artery; RCA, right coronary artery; RIM, intermediate branch; SVG, saphenous vein graft. | |||
Direct stenting | 105 (37.8) | 88 (38.3) | 17 (35.4) |
Target vessel | |||
LAD | 88 (31.7) | 74 (32.2) | 14 (29.2) |
LCX | 58 (20.9) | 45 (19.6) | 13 (27.1) |
RCA | 81 (29.1) | 71 (30.9) | 10 (20.8) |
RIM | 8 (2.9) | 8 (3.5) | 0 (0.0) |
SVG | 43 (15.5) | 32 (13.9) | 11 (22.9) |
Lesion characteristics | |||
AHA/ACC type A | 21 (7.6) | 17 (7.4) | 4 (8.3) |
AHA/ACC type B1 | 138 (49.6) | 123 (53.5) | 15 (31.3)* |
AHA/ACC type B2 | 92 (33.0) | 75 (32.6) | 17 (35.4) |
AHA/ACC type C | 27 (9.7) | 15 (6.5) | 12 (25.0)** |
Complications | |||
Dissection | 9 (3.2) | 4 (1.7) | 5 (10.4)* |
Side branch occlusion | 14 (5.0) | 12 (5.2) | 2 (4.2) |
Vasospasm | 3 (1.1) | 2 (0.9) | 1 (2.1) |
No reflow | 2 (0.7) | 0 (0.0) | 2 (4.2)* |
Medication | |||
Abciximab | 16 (5.8) | 12 (5.2) | 4 (8.3) |
Ticlopidine | 224 (80.6) | 189 (82.2) | 35 (72.9) |
Clopidogrel | 54 (19.4) | 41 (17.8) | 13 (27.1) |